JPRN-UMIN000017252已完成未知
ong-term usage of darbepoetin alpha in non-dialysis CKD patients - DREAM-J
Kyowa Hakko Kirin Co., Ltd.0 个研究点目标入组 3,000 人开始时间: 2015年4月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 3,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who are supposed to have dialysis or kidney transplant within 6-month
研究者
相似试验
已完成
不适用
The effect of intervention with darbepoetin alfa on progression of renal decline[chronic renal failure?] in renal anaemia patients with chronic kidney disease not on dialysis.renal anaemia patients with chronic kidney disease not on dialysisJPRN-UMIN000006963Division of Nephrology,Department of Internal Medicine,Juntendo University Faculty of Medicine200
进行中（未招募）
不适用
ONCE WEEKLY DOSING OF DARBEPOETIN ALPHA AS PROPHYLACTIC TREATMENT FOR ANEMIA IN ELDERLY CANCER PATIENTSELDERLY PATIENTS WITH GASTROINTESTINAL AND LUNG CANCERMedDRA version: 6.1Level: SOCClassification code 10029104EUCTR2005-003701-91-ITISTITUTO NAZIONALE PER LA CURA TUMORI
尚未招募
2 期
Phase II study of the addition of darbepoetin alfa (Aranesp) and pegfilgrastim (Neulasta) support for optimal dose-dense chemotherapy for early breast cancerCancer - BreastBreast CancerACTRN12605000731695Mater Adult hospital30
进行中（未招募）
不适用
Evaluation of the Efficacy of Darbepoetin Alfa for the Treatment of Anemia in Patients with Myelodysplastic Syndrome - DARB-MDSEUCTR2005-004737-17-ITAZIENDA OSPEDALIERA BIANCHI-MELACRINO-MORELLI54
已完成
不适用
Analysis on response to darbepoetin alfa in patients with low risk myelodysplastic syndromesJPRN-UMIN000022185Cooperative study between the West Japan Hematology Study Group and Clinical Research Support Center Kyushu85